CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
68.27%
Total 13F principal
$275,808,000
Principal change
-$8,196,000
Total reported market value
$187,842,325
Number of holders
19
Value change
-$16,048,327
Number of buys
8
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q1 2016

As of 31 Mar 2016, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 19 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $275,808,000 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, QVT Financial LP, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Allianz Asset Management AG, WELLS FARGO & COMPANY/MN, UBS OCONNOR LLC, Telemetry Investments, L.L.C., CAPSTONE INVESTMENT ADVISORS, LLC, and Castle Creek Arbitrage, LLC. This page lists 19 institutional bondholders reporting positions for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.